Spur Therapeutics Alternatives & Competitors
7 companies similar to Spur Therapeutics — Toward the next generation of gene therapy.
Companies similar to Spur Therapeutics
Exegenesis Bio
We are reimagining ways to develop & manufacture gene therapies. Our mission is to improv...
Spark Therapeutics, Inc.
This company is now integrated into the Roche Group, united in our commitment to do now wh...
Vivet Therapeutics
Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using li...
AAVantgarde
Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...
Track all Spur Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
AVROBIO
Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring perso...
Taysha Gene Therapies
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogeni...
MiNA Therapeutics
Activating RNA, mastering disease
About Spur Therapeutics
Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options for individuals suffe...
Gene Therapy, Liver-directed, Inherited Diseases, Clinical Trials, AAV-based Therapy, Hemophilia B, Fabry Disease, Gaucher Disease, Haemophilia A, Innovation, Global Locations, Systemic Diseases, United Kingdom, United States
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Spur Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Spur Therapeutics on 11 Sep 2024. The 7 companies listed here were last checked between 11 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.